Neurostimulation for the Treatment of Post-Stroke Aphasia
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- QVITI S.A.
- Study ID
- NCT05194566
- Status
- Recruiting
Conditions
- Post-stroke Aphasia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- tACS — DEVICENeurostimulation will be done using the Neuro Device tCS, which is a certified transcranial electrical stimulator. The device consists of a stimulator with a touch screen, two electrodes and a soft, flexible cap to ensure stability of the electrodes on the head.
Study Details
The aim of the trial is to determine whether 75Hz transcranial alternating current stimulation (tACS) synchronized with therapeutic linguistic tasks is an effective form of therapy for post-stroke aphasia.
Key Dates
- Start date
- Sep 6, 2023
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 64 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Real tACStACS 75Hz intervention combined with language tasks and breathing exercises. The device will operate in tACS research active stimulation mode.
- Sham Comparator: Sham tACStACS sham intervention combined with language tasks and breathing exercises. The device will operate in tACS sham simulation research mode.
Primary Outcome Measure
Percentage score in the Naming Task (trained words) [ Time Frame: 12-week follow-up ]
Central Contacts
- Tertia Jeppson312-238-6163
- Aidan Rogers(718) 308-9450
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Think & Speak Lab at Shirley Ryan AbilityLab | Chicago | Illinois | 60611 | Leora Cherney, PhD, CCC-SLP, BC-ANCDS, FACRM (PRINCIPAL_INVESTIGATOR) |
| Abilities Research Center at Mount Sinai | New York | New York | 10029 | Miguel Escalon, MD, MPH (PRINCIPAL_INVESTIGATOR) |